| P50 | author | Roseline Godbout | Q39184575 |
| | Catherine J. Field | Q39876299 |
| P2093 | author name string | Raja Mita | |
| | Michael J Beaulieu | |
| P2860 | cites work | Nuclear factor I regulates brain fatty acid-binding protein and glial fibrillary acidic protein gene expression in malignant glioma cell lines | Q24338788 |
| | Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription | Q24540092 |
| | Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma | Q24548280 |
| | Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme | Q24555728 |
| | Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus | Q24612974 |
| | The organization and consequences of eicosanoid signaling | Q24683703 |
| | Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein | Q27624921 |
| | Structural Basis for Activation of Fatty Acid-binding Protein 4 | Q27647673 |
| | Structural basis for the activation of PPARgamma by oxidized fatty acids | Q27653525 |
| | Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 |
| | Correlation of B-FABP and GFAP expression in malignant glioma | Q28271152 |
| | FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status | Q28297008 |
| | Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine | Q28361841 |
| | B-FABP-expressing radial glial cells: the malignant glioma cell of origin? | Q30480106 |
| | Introduction of point mutations into cloned genes | Q74321385 |
| | Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice | Q77556296 |
| | Adipocyte-type fatty acid-binding protein as inter-compartmental shuttle for peroxisome proliferator activated receptor gamma agonists in cultured cell | Q83017016 |
| | PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells | Q30484694 |
| | The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells | Q33372937 |
| | Omega-3 fatty acids as cancer chemopreventive agents | Q33781514 |
| | The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme | Q34542719 |
| | Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms | Q34548114 |
| | The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants | Q35171515 |
| | Canadian recommendations for the treatment of glioblastoma multiforme. | Q35855352 |
| | Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA | Q36116301 |
| | Cyclooxygenase-2 in hepatocellular carcinoma | Q36336021 |
| | Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids | Q37138726 |
| | The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy | Q37207725 |
| | Omega-6/omega-3 essential fatty acids: biological effects | Q37366317 |
| | Expression of E-FABP in PC12 cells increases neurite extension during differentiation: involvement of n-3 and n-6 fatty acids | Q37447318 |
| | Fatty acid binding proteins in brain development and disease | Q37766513 |
| | Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma | Q38326320 |
| | PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models | Q39849095 |
| | Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB. | Q40041253 |
| | The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion | Q40125579 |
| | Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts | Q40148949 |
| | Primary glioblastomas express mesenchymal stem-like properties | Q40233143 |
| | Analysis of tissue-specific and PPARalpha-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method | Q40683823 |
| | Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation | Q40683829 |
| | Thromboxane synthase regulates the migratory phenotype of human glioma cells | Q40781384 |
| | Influence of n-3 fatty acids on the growth of human breast cancer cellsin vitro: Relationship to peroxides and Vitamin-E | Q41341561 |
| | The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. | Q42456749 |
| | Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells | Q42805491 |
| | NMR and gas chromatography studies of lyophilized human brain tumors. | Q43108708 |
| | Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor | Q44375278 |
| | Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas | Q44700024 |
| | Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study | Q46708591 |
| | Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment | Q48455274 |
| | The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue | Q48848942 |
| | Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy. | Q50581029 |
| | Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4 | Q54833634 |
| | Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. | Q55469726 |
| | Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. | Q55475169 |
| | Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines. | Q55475411 |
| | Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver | Q73222988 |
| | Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells | Q73263444 |
| | Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice | Q73332347 |
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 37005-37015 | |
| P577 | publication date | 2010-09-12 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration | |
| P478 | volume | 285 | |